|
1.IntroductionNitric oxide (NO) has been shown to be an important signaling molecule in a wide variety of physiological and pathological processes, such as the modulation of the immune and endocrine response, cardiovascular control, regulation of blood pressure, neurotransmission, induction of apoptosis, and inhibition of tumor growth.1–5 Since these discoveries, research efforts have been directed toward development of exogenous NO donors that can deliver NO to specific biological targets. Various NO donors have been developed and have been clinically used as drugs, including organic nitrites and nitrates, nitrosothiols, diazeniumdiolates (NONOates), and transition metal based NO donors, such as sodium nitroprusside.6–10 However, these compounds and complexes release NO spontaneously; controlled or favorably triggered release of NO at a selected site is the key way for successful employment of an NO donor in regulation of physiological processes and treatment of diseases. Metal nitrosyl complexes release NO only when exposed to light, which makes them candidates of choice with the advent of photodynamic therapy (PDT). Compared to most alternative metal complexes, ruthenium nitrosyls are especially appealing and provided the most promising candidates in relation to their inherent stability in aqueous media and modest photosensitivity.11–13 The photochemical activation of these complexes is utilized for clinical therapy for targeted cancer and other diseases.14–16 Furthermore, the reactivities and biological properties of metal complexes significantly vary depending on their isomeric structures. A classic example of metal-based anticancer drugs with dramatically different biological activities is cis- and trans-platin, of which cis-platin is the widely clinically used anticancer agent, while its corresponding trans isomer shows less anticancer activities. Recently, several classes of trans-configured complexes have been reported to exhibit higher cytotoxicities, which lack cross-resistance to cis-platin. An example of such complexes is , where .17–19 Two other excellent trial drugs, (NAMI-A) and (KP1019), are also currently undergoing human clinical trials.20–23 In this study, the photoinduced NO release by two geometrical isomers of nitrosylruthenium(II) complex with 2mqn () as a ligand was investigated. Figure 1 presents the structures of the cis and trans isomers as well as that of the H2mqn ligand. The photodissociation of isomers and quantitative determination of NO were characterized by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The spin trapping of NO-free radicals was conducted via electron paramagnetic resonance (EPR) spectroscopy, and the NO release was monitored by electrochemistry using an NO-specific electrode. The basic method was developed to quantitatively control NO release in aqueous solutions by photoirradiation. Furthermore, density functional theory (DFT) calculations were also performed to understand the photodissociation of NO, the photoinduced damage on plasmid DNA, and the photoincreased cytotoxicity against tumor cell lines by these isomer complexes. This study provided insight into the photocontrolled NO release and its potential applications in photobiology and medicine. 2.Methods and Materials2.1.Chemicals and ReagentsChemical reagents and solvents were purchased from local available sources. The calf thymus DNA and supercoiled (CsCl purified) pBR322DNA were purchased from Takara (Japan). The spin trapper N-methyl-D-glucamine dithiocarbamate (MGD) and 5,5-dimethyl-1-pyrroline N-oxide (DMPO) were purchased from Dojindo (Japan). 2,2,6,6-Tetramethylpiperidine 1-oxyl (TEMPO) was purchased from Sigma. Cis- and trans- complexes were synthesized following a previously described procedure.24,25 Hydrous nitrosylruthenium trichloride (0.5 mmol) and 2-methyl-8-quinolinol (2.0 mmol) were mixed in 0.1 M acetic acid aqueous solution and the solution was refluxed for 5 h under dinitrogen in the dark. After cooling, the precipitate was collected by filtration and dried under vacuum. The crude product was chromatographically separated using a silica-gel column. The cis isomer complex was eluted from the major band with 30 vol.% . The cis complex (0.1 mmol) was dissolved in , and the solution was irradiated with an Xe lamp through a combination of a UV cut filter and a water filter for 5 h at room temperature. After the solvent was removed, the trans isomer was chromatographically separated using as an eluent with a yield of 20%. The cis and trans isomer complexes were confirmed through NMR spectra using a Bruker 600 M spectrometer. 2.2.Instruments and MeasurementsMALDI-TOF MS measurements were performed using a BIFLEX III MALDI-TOF mass spectrometer (Bruker Daltonics) equipped with a nitrogen laser (). The mass spectra (20 summed shots) were acquired in the reflector mode with a 19 kV accelerating voltage and a 20 kV reflector voltage. matrix was used for the MALDI experiment. The matrix solution and analyte solution were mixed and the result was spotted on the MALDI target plate. After air-drying, the samples were analyzed. EPR spectra were obtained at room temperature by using a Bruker ESP-300E spectrometer at 9.8 GHz, X-band, with a 100 Hz field modulation. Cis or trans isomers in DMSO at 5 mM, mixed with , was quantitatively injected into quartz capillaries and then was illuminated in the cavity of the EPR spectrometer with an Nd:YAG laser at 532 nm (5 to 6 ns of pulse width, 10 Hz of repetition, ). Nanosecond laser pulses for excitation at 355 nm were generated by an : YAG laser. The excitation energy of each pulse was . All measurements were performed at room temperature. Real-time measurements of NO were conducted by electrochemistry on TBR4100 four-channel free radical analyzer (World Precision Instruments, USA) equipped with a wide range NO-selective electrode (WPI). The ISO-NOP NO meter (2 mm) was vertically and directly immersed inside the quartz cuvette containing complex solution in 10 mM phosphate buffer at pH 7.4. The TBR4100 analyzer is interfaced with PC via Lab-Trax system. The data are acquired in real time by using the LabScribe software. To avoid any reaction before the light irradiation, the samples were protected from light by using an aluminum foil. The NO release profile was constructed by plotting the current versus time. The current of the buffer solution was set as a zero baseline to calculate the current increment. The complex solution of different isomers in the quartz cuvette was irradiated by an Xe lamp (300 W, Beijing NBeT Corp.) at the central wavelengths of 254, 420, and 550 nm with a bandwidth of 40 nm by several band-pass filters. The irradiation power measured by an optical power meter (LPE-1B, Physcience Opto-Electronics, Beijing) was kept constant at by adjusting the lamp current and the distance between the light source and sample. 2.3.DFT CalculationsDFT calculations were performed using the Gaussian 09 program package.26 The original coordinates of the cis and trans isomer atoms were obtained from the crystal structures determined via x-ray diffraction. Visualization was performed using Gaussian view 5.27 All geometries were fully optimized without imposing any symmetry constraint with the Becke’s three-parameter hybrid function with the Lee-Yang-Parr correlation function.28,29 The standard Wadt-Hay realistic effective core potentials were incorporated in the Gaussian 09 to describe the core electrons of the Ru atom. The 6-311G (d, p) was used for the ligand atoms. The frequency calculated at the DFT level was compared with the experimental frequency to check whether the stationary points from the geometry optimization were in real minima. 2.4.Photoinduced DNA DamageThe photoinduced DNA damage by the two isomers was investigated via agarose gel electrophoresis. A supercoiled pBR322 DNA () was mixed with a two isomer complexes solution at 50 mM, respectively, and incubated at 37°C for 30 min in the dark. The solution was then irradiated at room temperature by an Xe light source with 420-nm bandpass filters () for 0.5 h. The samples were analyzed via electrophoresis for 1 h at 90 V on a 1% agarose gel in buffer (40 mM , 1 mM ethylenediaminetetraacetic acid, ). The gel was stained with EB and photographed under UV light. The mechanistic investigations of pBR322DNA were conducted using free radical scavengers, sodium azide (, 3 mM), which were added to pBR322 DNA prior to the addition of the complex. 2.5.Cytotoxic ActivityA HeLa tumor cell line was used in this study with standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay procedures. Cells were seeded in 96-well plates () in growth medium () and incubated at 37°C under a 5% atmosphere for 24 h, and then were treated with various concentrations of complexes in a mixture of growth medium. The complexes were dissolved in DMSO and diluted with Roswell Park Memorial Institute medium 1640, and then added to the wells at a different final concentration. The concentration of DMSO was controlled . Control wells were prepared by the addition of a culture medium () without complexes, which was also incubated at 37°C under a 5% atmosphere for 24 h. MTT ( of ) was added to each well, and then the plates were further incubited for 4 h. The culture medium was finally discarded, and of DMSO was added to solubilize the MTT. The solution absorbance at 490 nm was measured with a microplate-reader. The values of complexes were determined by plotting the viability percentage versus concentration on a logarithmic scale and reading off the concentration at which 50% of cells were viable relative to the control. For comparing the effect of photoirradiation on the cytotoxic activity of isomer complexes, cell cultures upon photoirradiation were performed at the same conditions. After adding complex isomers in a mixture of growth medium at various concentrations, the cells were incubated at 37°C under a 5% atmosphere for 4 h; then the plates were irradiated with a light source of 420 nm () for 30 min and again were incubated at 37°C in a 5% incubator for 24 h. Upon completion of the incubation, a stock MTT dye solution (, ) was added to each well. After 4 h of incubation, the culture medium was finally discarded, and of DMSO was added to solubilize the MTT. The optical density of each well was then measured using a microplate spectrophotometer at 490 nm. Each experiment was repeated at least three times to obtain the mean values. 3.Results3.1.Photoinduced NO Release3.1.1.MALDI-TOF MS spectraTo identify the products of photoinduced fragmentation, MALDI-TOF MS was used to analyze the isomer complexes. Two main mass signals appearing in MALDI-TOF MS spectrum are attributed to the fragments of (, ) and (, ). The calculated mass of was 507.0 Da, and the fragment of was formed by the loss of the –OAc group with a mass of 59.0 Da. The other fragment of was formed by the loss of –OAc and –NO with a mass of 30.0 Da. The molecular ion peak of was not observed for both isomers upon photoexcitation, indicating that was completely dissociated by losing the –OAc group and further dissociated to by losing the NO group upon photoirradiation. 3.1.2.EPR spectroscopyIron(II)-N-methyl-D-glucamine dithiocarbamate [] is commonly used to trap NO because of its high probability of adduct formation and the high stability of its spin adduct. Spin trapping, together with EPR spectroscopy by using is considered as one of the best methods for detecting in real time and at its generation site.30,31 Both isomers produced NO free radicals through photoexcitation at either 355 or 532 nm. Figure 2 shows the characteristic triplet signal with a hyperfine splitting constant (hfsc) value of and a g-factor of , which is consistent with the literature report for adduct.32,33 More free radical molecules were generated at the photoexcitation of 355 nm than at the photoexcitation of 532 nm, and the trans isomers produced a little more free radicals at a photoexcitation of 355 nm than the cis isomers at the same conditions. 3.1.3.DFT calculationsDFT calculations were successfully used for investigating the reactivities of ruthenium complexes.34 Figure 3 shows the energy levels and contour plots of the frontier orbitals of cis- and trans- complexes. For both isomers, the highest occupied molecular orbital (HOMO) was a 2mqn ligand-based orbital with minimal Ru () and NO (), whereas the lowest unoccupied molecular orbital (LUMO) was the antibonding overlap of Ru () and . The orbital analyses indicate that the direct excitation of an electron from a bonding orbital to an antibonding orbital causes the photorelease of NO from ruthenium–nitrosyls. The previous studies on ruthenium polypyridyl complexes {such as [], } found that the HOMO was centered on the ruthenium represented by Ru () , whereas the LUMO was localized on the bpy (). Metal-to-ligand charge transfer transition has an important function in photochemical and photophysical processes of these ruthenium-N-donor complexes.35,36 The different transition contributions of the HOMOs−LUMOs of Ru complexes lead to different pathways and patterns for the exited state, thereby resulting in the formation of different free radical species. As shown in Fig. 3, the calculated energy of the HOMO–LUMO gap for the trans isomer was smaller than that of the cis isomer, which suggests that the trans isomer is more active upon photoirradiation, agreeing with the experimental observations. 3.2.Real-Time Measurement of NO ReleaseReal-time NO release was measured by the electrochemistry with the free radical analyzer. The NO release increased for both isomers at the photoexcitation of 550, 420, and 254 nm, and white light. Photoirradiation wavelength positions are selected according to the measured absorption spectra: around the absorption peak in the visible region (420 nm); around the lower-absorption region (550 nm); around the absorption peak in the UV region (254 nm); and, finally, white light containing all wavelengths in the visible region. As shown in Fig. 4, the amount of released NO increased as the irradiated wavelength moving from visible region to UV region reached a maximum under white light irradiation; the amount of NO production increased as the absorbance increased in absorption spectra. Therefore, the NO release could be controlled by varying the irradiation wavelength. Moreover, the trans isomers produced slightly more NO free radicals than the cis isomers at the same conditions. 3.3.Photoinduced DNA DamageSince DNA was identified as the primary target of metal-based anticancer agents, considerable attention has been drawn into the interaction of ruthenium complexes with DNA for the potential of ruthenium complexes as chemotherapeutic agents. Further studies on the mechanism show that ruthenium complexes containing polypyridyl, imidazole, and -carboline derivatives are antiproliferative and able to induce caspase-dependent apoptosis in cancer cells with mitochondrial dysfunction.37–40 The photoinduced effect and damage of the isomers on plasmid DNA were monitored via agarose gel electrophoresis. When circular plasmid DNA is subjected to electrophoresis, a relatively fast migration is generally observed for the intact supercoiled Form I. While the scission occurs on one strand (nicking), the supercoil relaxes to generate a slower-moving, open-circular Form II. If DNA conformation was further changed, a broader linear Form III between Forms I and II is generated.41–43 Figure 5 shows the photoinduced damage of pBR322 DNA by isomers. No change was observed in the control experiment (Lane 1) compared with the incubation of the plasmid DNA with the complex in the dark (Lane 2). After irradiation at 420 nm for 30 min, of the complex caused an apparent conformational change of DNA because Form I disappeared and Form III (Lane 3) appeared. These results demonstrate that DNA damage occurred through the photoinduced reaction pathway. In the presence of , a well-known scavenger of singlet oxygen (), there is no evident inhibition of DNA damage for both isomers (Lane 7). By contrast, efficiently inhibited DNA cleavage for Ru(II) polypyridyl complexes, in which was detected by an EPR spin trapping technique and caused DNA strand cleavage.44,45 3.4.PhotocytotoxicityMTT assay was conducted to evaluate the photocytotoxic potential of the isomer complexes upon photoexcitation using human cervical HeLa cancer cells as shown in Fig. 6. Upon prior incubation for 4 h in the dark and the subsequent exposure to light of 420 nm for 30 min, the trans isomer showed a moderate decrease in the cell viability with values of under the light and in the dark. The trans isomers exhibited better cytotoxicity and photocytotoxicity activity against the HeLa tumor cell line. Cis-platin is known to give an value of in the dark for HeLa cells after 24 h incubation. Incubation of HeLa cells with cis-platin for 4 h in the dark and subsequent exposure to UV-A light gave values of under UV-A light of 365 nm, thus showing no apparent PDT effect.46 The cis isomer gave an value of with the cells unexposed to light, while it gave an value of with the cells exposed to light. Therefore, the cis isomers are less toxic and show very low cytotoxicity against the HeLa tumor cell line in dark, but its cytotoxicity activity increased to some extent upon photoirradiation. 4.DiscussionSeveral studies have implied that biological effects of NO depend on the concentration of NO in the biological milieu.47–49 Therefore, it is very important to detect and quantitatively control NO release from an NO-donating agent at physiological targets for application in biomedicine. In order to achieve the effective regulation of physiological and pathological processes, the photodissociation of two () isomers was investigated by MALDI-TOF MS, and the spectra showed two main mass signals corresponding to the fragments of with the loss of the –OAc group and with the further loss of the NO group. The spin trapping of NO free radicals, with as the scavenger, was also detected via EPR spectroscopy. The photoinduced NO release from was confirmed and the real-time NO release upon photoirradiation at different wavelengths from visible to UV were investigated. The NO release could be controlled by using different irradiation wavelengths. Furthermore, the trans isomer produces slightly more NO upon photoirradiation than the cis isomer at the identical concentration. In biological systems, reactive oxygen/nitrogen species have an important function for regulating cell function, signaling, and immune response; however, these species reduce cell viability in unregulated concentrations. These free radicals can cause oxidative damage to biomolecules by the loss of protein function, DNA cleavage, or lipid peroxidation, and ultimately to oxidative stress, which finally results in cell injury or death.50 To further investigate the mechanism, the spin trapping of and free radicals from two isomers by EPR measurements was performed upon photoirradiation. DMPO was used for detection and TEMPO for detection. However, in this study, no free radical signal was detected via EPR spectroscopy with and without photoirradiation, except for the NO free radicals. Therefore, in contrast to the results of the extensively studied Ru(II) polypyridyl complexes, NO free radicals and photodissociated species from complexes have a great impact on the conformational change of DNA. Both cis and trans isomers show obvious photoinduced damage on plasmid DNA; however, the trans isomer shows higher cytotoxicity activity against the HeLa tumor cell line than cis isomer. The origin of cis-/trans- effect may be attributed to the different molecular polarity and electronic properties arising from different geometries of isomer complexes, which may lead to different behaviors of isomers in metabolism in vivo, transmembrane as well as different interactions with the cellular target. Furthermore, it is still needed to increase the efficiency of light absorption and the yield of nitric oxide released for isomer complexes upon photoirradiation to enhance the light-induced cellular effect. Overall, the photoactivities of different Ru complexes will give deep insight as to how to synthetically control the complex structure for the desired NO release as compared with traditional methods. These promising findings suggest that nitrosylruthenium(II) complex containing 8-quinolinol derivatived ligands as a potential NO-donor reagent will spur researchers to pursue investigations on the nitrosylruthenium(II) complexes as potential photoactivated dual-action regents with biomedicinal applications. AcknowledgmentsResearch project was supported by the National Natural Science Foundation of China (J1103210). The Talent Plan of Shanxi Province and Shanxi Scholarship Council of China are gratefully acknowledged. ReferencesL. J. Ignarroet al., Nitric Oxide: Biology and Pathobiology, Academic Press, San Diego
(2000). Google Scholar
D. Fukumuraet al.,
“The role of nitric oxide in tumour progression,”
Nat. Rev. Cancer, 6
(7), 521
–534
(2006). http://dx.doi.org/10.1038/nrc1910 NRCAC4 1474-175X Google Scholar
J. O. Lundberget al.,
“Nitrate and nitrite in biology, nutrition and therapeutics,”
Nat. Chem. Biol., 5
(12), 865
–869
(2009). http://dx.doi.org/10.1038/nchembio.260 1552-4450 Google Scholar
D. Hirstet al.,
“Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy,”
Curr. Pharm. Des., 16
(4), 411
–420
(2010). http://dx.doi.org/10.2174/138161210790232185 CPDEFP 1381-6128 Google Scholar
A. G. Tennysonet al.,
“Generation, translocation, and action of nitric oxide in living systems,”
Chem. Biol., 18
(10), 1211
–1220
(2011). http://dx.doi.org/10.1016/j.chembiol.2011.09.009 CBOLE2 1074-5521 Google Scholar
C. Napoliet al.,
“Nitric oxide-releasing drugs,”
Annu. Rev. Pharmacol. Toxicol., 43 97
–123
(2003). http://dx.doi.org/10.1146/annurev.pharmtox.43.100901.140226 ARPTDI 0362-1642 Google Scholar
P. G. Wanget al., Nitric Oxide Donors for Pharmaceutical and Biological Applications, Wiley-VCH, Weinheim
(2005). Google Scholar
G. R. Thatcheret al.,
“An introduction to NO-related therapeutic agents,”
Curr. Top. Med. Chem., 5
(7), 597
–601
(2005). http://dx.doi.org/10.2174/1568026054679281 1568-0266 Google Scholar
D. Hirstet al.,
“Targeting nitric oxide for cancer therapy,”
J. Pharm. Pharmacol., 59
(1), 3
–13
(2007). http://dx.doi.org/10.1211/jpp.59.1.0002 JPPMAB 0022-3573 Google Scholar
E. V. Stevenset al.,
“Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth,”
Mol. Pharm., 7
(3), 775
–785
(2010). http://dx.doi.org/10.1021/mp9002865 1543-8384 Google Scholar
K. J. Franzet al.,
“Nitrosyl transfer from manganese to iron in tropocoronand complexes,”
Inorg. Chem., 39
(16), 3722
–3723
(2000). http://dx.doi.org/10.1021/ic000360n INOCAJ 0020-1669 Google Scholar
F. Derosaet al.,
“Chromium(III) complexes for photochemical nitric oxide generation from coordinated nitrite: synthesis and photochemistry of macrocyclic complexes with pendant chromophores, trans-[Cr(L)(ONO)(2)]BF(4),”
Inorg. Chem., 44
(12), 4157
–4165
(2005). http://dx.doi.org/10.1021/ic048311o INOCAJ 0020-1669 Google Scholar
N. L. Fryet al.,
“Photoactive ruthenium nitrosyls as NO donors: how to sensitize them toward visible light,”
Acc. Chem. Res., 44
(4), 289
–298
(2011). http://dx.doi.org/10.1021/ar100155t ACHRE4 0001-4842 Google Scholar
M. J. Roseet al.,
“Sensitization of ruthenium nitrosyls to visible light via direct coordination of the dye resorufin: trackable NO donors for light-triggered NO delivery to cellular targets,”
J. Am. Chem. Soc., 130
(27), 8834
–8846
(2008). http://dx.doi.org/10.1021/ja801823f JACSAT 0002-7863 Google Scholar
A. C. Pereiraet al.,
“Ruthenium-nitrite complex as pro-drug releases NO in a tissue and enzyme-dependent way,”
Nitric Oxide, 24
(4), 192
–198
(2011). http://dx.doi.org/10.1016/j.niox.2011.03.001 NIOXF5 1089-8603 Google Scholar
A. C. Merkleet al.,
“Spectroscopic analysis and photolabilization of water-soluble ruthenium(III)-nitrosyl complexes,”
Dalton Trans., 41
(26), 8047
–8059
(2012). http://dx.doi.org/10.1039/c2dt30464c DTARAF 1477-9226 Google Scholar
Y. Y. Scaffidi-Domianelloet al.,
“Novel cis- and trans-configured bis(oxime)platinum(II) complexes: synthesis, characterization, and cytotoxic activity,”
Inorg. Chem., 49
(12), 5669
–5678
(2010). http://dx.doi.org/10.1021/ic100584b INOCAJ 0020-1669 Google Scholar
C. Bartelet al.,
“Cellular accumulation and DNA interaction studies of cytotoxic trans-platinum anticancer compounds,”
J. Biol. Inorg. Chem., 17
(3), 465
–474
(2012). http://dx.doi.org/10.1007/s00775-011-0869-5 0949-8257 Google Scholar
V. B. Arionet al.,
“Synthesis, x-ray diffraction structures, spectroscopic properties, and in vitro antitumor activity of isomeric (1H-1,2,4-triazole) Ru(III) complexes,”
Inorg. Chem., 42
(19), 6024
–6031
(2003). http://dx.doi.org/10.1021/ic034605i INOCAJ 0020-1669 Google Scholar
E. S. AntonarakisA. Emadi,
“Ruthenium-based chemotherapeutics: are they ready for prime time?,”
Cancer Chemother. Pharmacol., 66
(1), 1
–9
(2010). http://dx.doi.org/10.1007/s00280-010-1293-1 CCPHDZ 0344-5704 Google Scholar
E. Alessioet al.,
“Ruthenium antimetastatic agents,”
Curr. Top. Med. Chem., 4
(15), 1525
–1535
(2004). http://dx.doi.org/10.2174/1568026043387421 1568-0266 Google Scholar
C. G. Hartingeret al.,
“A new redox-active anticancer agent—preclinical development and results of a clinical phase I study in tumor patients,”
Chem. Biodivers., 5
(10), 2140
–2155
(2008). http://dx.doi.org/10.1002/cbdv.v5:10 CBHIAM 1612-1872 Google Scholar
A. Levinaet al.,
“Recent developments in ruthenium anticancer drugs,”
Metallomics, 1
(6), 458
–470
(2009). http://dx.doi.org/10.1039/b904071d METAJS 1756-5901 Google Scholar
K. Mikiet al.,
“Crystal structures of three geometrical isomers of [Ru(OAc)(2mqn)2 NO] (, ) and their thermal isomerization reactions,”
Inorg. Chim. Acta, 257
(1), 3
–10
(1997). http://dx.doi.org/10.1016/S0020-1693(96)05394-7 ICHAA3 0020-1693 Google Scholar
H. Wanget al.,
“Electronic effects of the substituent group in 8-quinolinolato ligand on geometrical isomerism for nitrosylruthenium(II) complexes,”
Inorg. Chim. Acta, 299
(1), 80
–90
(2000). http://dx.doi.org/10.1016/S0020-1693(99)00464-8 ICHAA3 0020-1693 Google Scholar
M. J. Frischet al., Gaussian 09, Revision C.01, Gaussian, Inc., Wallingford, CT
(2009). Google Scholar
R. Denningtonet al., GaussView, Version 5, Semichem Inc., Shawnee Mission, KS
(2009). Google Scholar
C. Leeet al.,
“Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density,”
Phys. Rev. B, 37
(2), 785
–789
(1988). http://dx.doi.org/10.1103/PhysRevB.37.785 PRBMDO 0163-1829 Google Scholar
A. D. Becke,
“Density-functional thermochemistry. III. The role of exact exchange,”
J. Chem. Phys., 98
(7), 5648
–5652
(1993). http://dx.doi.org/10.1063/1.464913 JCPSA6 0021-9606 Google Scholar
A. F. Vaninet al.,
“Why iron-dithiocarbamates ensure detection of nitric oxide in cells and tissues,”
Nitric Oxide, 15
(4), 295
–311
(2006). http://dx.doi.org/10.1016/j.niox.2005.11.007 NIOXF5 1089-8603 Google Scholar
S. Porasuphatanaet al.,
“Differential effect of buffer on the spin trapping of nitric oxide by iron chelates,”
Anal. Biochem., 298
(1), 50
–56
(2001). http://dx.doi.org/10.1006/abio.2001.5389 ANBCA2 0003-2697 Google Scholar
B. Gopalakrishnanet al.,
“Detection of nitric oxide and superoxide radical anion by electron paramagnetic resonance spectroscopy from cells using spin traps,”
J. Vis. Exp., 66 2810
(2012). http://dx.doi.org/10.3791/2810 JVEOA4 1940-087X Google Scholar
S. Pouet al.,
“Spin trapping of nitric oxide by ferro-chelates: kinetic and in vivo pharmacokinetic studies,”
Biochim. Biophys. Acta, 1427
(2), 216
–226
(1999). http://dx.doi.org/10.1016/S0304-4165(99)00014-8 BBACAQ 0006-3002 Google Scholar
M. K. Nazeeruddinet al.,
“Combined experimental and DFT-TDDFT computational study of photoelectrochemical cell ruthenium sensitizers,”
J. Am. Chem. Soc., 127
(48), 16835
–16847
(2005). http://dx.doi.org/10.1021/ja052467l JACSAT 0002-7863 Google Scholar
Q. J. Panet al.,
“Structures, spectroscopic properties and redox potentials of quaterpyridyl Ru(II) photosensitizer and its derivatives for solar energy cell: a density functional study,”
Phys. Chem. Chem. Phys., 13
(32), 14481
–14489
(2011). http://dx.doi.org/10.1039/c1cp00030f PPCPFQ 1463-9076 Google Scholar
D. A. Luttermanet al.,
“Theoretical insight on the S→O photoisomerization of DMSO complexes of Ru(II),”
J. Phys. Chem. A, 113
(41), 11002
–11006
(2009). http://dx.doi.org/10.1021/jp903048n JPCAFH 1089-5639 Google Scholar
L. Liet al.,
“Ruthenium complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers,”
Dalton Trans., 41
(4), 1138
–1141
(2012). http://dx.doi.org/10.1039/c1dt11950h DTARAF 1477-9226 Google Scholar
C. Tanet al.,
“Synthesis, structures, cellular uptake and apoptosis-inducing properties of highly cytotoxic ruthenium-Norharman complexes,”
Dalton Trans., 40
(34), 8611
–8621
(2011). http://dx.doi.org/10.1039/c1dt10084j DTARAF 1477-9226 Google Scholar
T. F. Chenet al.,
“Ruthenium polypyridyl complexes that induce mitochondria-mediated apoptosis in cancer cells,”
Inorg. Chem., 49
(14), 6366
–6368
(2010). http://dx.doi.org/10.1021/ic100277w INOCAJ 0020-1669 Google Scholar
C. Tanet al.,
“Nuclear permeable ruthenium(II) -carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis,”
J. Med. Chem., 53
(21), 7613
–7624
(2010). http://dx.doi.org/10.1021/jm1009296 JMCMAR 0022-2623 Google Scholar
A. Srishailamet al.,
“Synthesis, DNA-binding, cytotoxicity, photo cleavage, antimicrobial and docking studies of Ru(II) polypyridyl complexes,”
J. Fluoresc., 23
(5), 897
–908
(2013). http://dx.doi.org/10.1007/s10895-013-1209-7 JOFLEN 1053-0509 Google Scholar
X. L. Zhaoet al.,
“Synthesis, pH-induced ‘on-off-on’ luminescence switching, and partially intercalative DNA-binding and DNA photocleavage properties of an β-D-allopyranoside-grafted ruthenium(II) complex,”
J. Inorg. Biochem., 113 66
–76
(2012). http://dx.doi.org/10.1016/j.jinorgbio.2012.03.010 JIBIDJ 0162-0134 Google Scholar
J. F. Kouet al.,
“Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II,”
J. Biol. Inorg. Chem., 17
(1), 81
–96
(2012). http://dx.doi.org/10.1007/s00775-011-0831-6 0949-8257 Google Scholar
Q. X. Zhouet al.,
“Ruthenium(II) terpyridyl complexes exhibiting DNA photocleavage: the role of the substituent on monodentate ligand,”
J. Phys. Chem. B, 113
(33), 11521
–11526
(2009). http://dx.doi.org/10.1021/jp905506w JPCBFK 1520-6106 Google Scholar
X. L. Zhaoet al.,
“DNA- and RNA-binding and enhanced DNA-photocleavage properties of a ferrocenyl-containing ruthenium(II) complex,”
J. Inorg. Biochem., 107
(1), 104
–110
(2012). http://dx.doi.org/10.1016/j.jinorgbio.2011.10.007 JIBIDJ 0162-0134 Google Scholar
A. Hussainet al.,
“Photocytotoxic lanthanum(III) and gadolinium(III) complexes of phenanthroline bases showing light-induced DNA cleavage activity,”
Inorg. Chem., 49
(9), 4036
–4045
(2010). http://dx.doi.org/10.1021/ic901791f INOCAJ 0020-1669 Google Scholar
D. A. Wink,
“Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide,”
Free Radic. Biol. Med., 25
(4), 434
–456
(1998). http://dx.doi.org/10.1016/S0891-5849(98)00092-6 FRBMEH 0891-5849 Google Scholar
D. Mancardi,
“The chemical dynamics of NO and reactive nitrogen oxides: a practical guide,”
Curr. Mol. Med., 4
(7), 723
–740
(2004). http://dx.doi.org/10.2174/1566524043359854 CMMUBP 1566-5240 Google Scholar
B. Bonavida,
“Dual role of NO donors in the reversal of tumor cell resistance and EMT: downregulation of the NF-κB/Snail/YY1/RKIP circuitry,”
Nitric Oxide, 24
(1), 1
–7
(2011). http://dx.doi.org/10.1016/j.niox.2010.10.001 NIOXF5 1089-8603 Google Scholar
C. C. Winterbourn,
“Reconciling the chemistry and biology of reactive oxygen species,”
Nat. Chem. Biol., 4
(5), 278
–286
(2008). http://dx.doi.org/10.1038/nchembio.85 1552-4450 Google Scholar
BiographyJiao Liu received her BS degree from Shanxi University, China, and is currently a graduate student at the Key Laboratory of Chemical Biology and Molecular Engineering of the Education Ministry, Institute of Molecular Science, Shanxi University. Her current research involves cell biology and biomedical optics. Qingqing Duan received her BS degree from Taiyuan University of Science and Technology, China, and is currently a graduate student at the State Key Lab of Quantum Optics and Quantum Optics Devices, Institute of Opto-Electronics, Shanxi University. Her current research involves laser biology and biomedical optics. Jianru Wang received her MS degree from Beijing University of Technology, China, in 2007, and she was an assistant professor at Shanxi Medical University. She is currently a graduate student at State Key Lab of Quantum Optics and Quantum Optics Devices, Institute of Opto-Electronics, Shanxi University. Her current research involves laser biology and biomedical optics. Zhen Song received her PhD degree in 2014 from Key Laboratory of Chemical Biology and Molecular Engineering of the Education Ministry, Institute of Molecular Science, Shanxi University. She is currently an assistant professor at Taiyuan Normal University, China. Her current research involves bioinorganic chemistry and chemical biology. Xiaoyan Qiao received her PhD degree from Tianjin University, China, in 2007. She is currently an associate professor in the College of Physics and Electronics Engineering, Shanxi University. Her current research involves biophysics and biomedical optics. Hongfei Wang received his PhD degrees from Nanjing University, China, in 1996 and from Rikkyo University, Japan, in 2001. He was a postdoctoral research associate in the Institute of Physical and Chemical Research (RIKEN), Japan. He is presently a professor at Shanxi University, China. His current research involves photophysics and photochemistry, as well as biomedical optics. |